OAKLAND, Calif. -- Women who experience gestational diabetes may face an increased risk of early heart disease later in life, even if they do not develop type 2 diabetes or metabolic syndrome subsequent to their pregnancy, according to a Kaiser Permanente study published today in the Journal of the American Heart Association.
"Our research shows that just having a history of gestational diabetes elevates a woman's risk of developing early atherosclerosis before she develops type 2 diabetes or metabolic syndrome," said Erica P. Gunderson, PhD, MPH, study lead author and senior research scientist in the Kaiser Permanente Division of Research in Oakland, Calif. "Pregnancy has been under-recognized as an important time period that can signal a woman's greater risk for future heart disease. This signal is revealed by gestational diabetes."
Gestational diabetes, a condition of elevated blood sugar during pregnancy, usually disappears after the pregnancy. It is managed with meal planning, activity and sometimes insulin or other medications.
In the 20-year study, researchers assessed risk factors for heart disease before pregnancy among 898 women, 18 to 30 years old, who later had one or more births. The women were periodically tested for diabetes and metabolic conditions before and after their pregnancies. Using ultrasound, researchers measured the thickness of the walls of participants' carotid artery, which circulates blood to the neck and face. Carotid artery wall thickness is an early measure of atherosclerosis -- plaque build-up in arteries -- and predicts heart attack and stroke in women. The artery's thickness was measured on average 12 years after pregnancy.
Researchers found a larger average carotid artery wall thickness in study participants with a history of gestational diabetes who did not develop diabetes or metabolic syndrome during the 20-year follow-up compared to those who never experienced gestational diabetes.. The difference was not attributed to obesity or other risk factors for heart disease that were measured before pregnancy.
It's important to recognize reproductive characteristics that may contribute to disease risk in women, Gunderson said. "It's a shift in thinking about how to identify a subgroup at risk for atherosclerosis early. The concept that reproductive complications unmask future disease risk is a more recent focus. It may inform early prevention efforts."
This study is part of Kaiser Permanente's ongoing efforts to better understand gestational diabetes. Last year, Kaiser Permanente researchers found that pre-pregnancy obesity and older maternal age are among the risk factors for delayed lactation for women with gestational diabetes.
Kaiser Permanente can conduct transformational health research in part because it has the largest private patient-centered electronic health system in the world. The organization's electronic health record system, Kaiser Permanente HealthConnect®, securely connects 9.1 million patients to more than 16,000 physicians in almost 600 medical offices and 38 hospitals. It also connects Kaiser Permanente's research scientists to one of the most extensive collections of longitudinal medical data available, facilitating studies and important medical discoveries that shape the future of health and care delivery for patients and the medical community.
Other authors on the study include Vicky Chiang, MSPH, Charles P. Quesenberry Jr., PhD, and Stephen Sidney, MD, of the Kaiser Permanente Division of Research, Oakland, Calif.; Mark J. Pletcher, MD, MPH, of the Department of Epidemiology and Biostatistics, University of California, San Francisco; David R. Jacobs Jr., PhD, of the Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis; and Cora E. Lewis, MD, MSPH, of the Division of Preventive Medicine, University of Alabama at Birmingham.
This research was funded in part by the National Institutes of Health (K01 DK059944).
About the Kaiser Permanente Division of Research
The Kaiser Permanente Division of Research conducts, publishes and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well-being and to improve the quality and cost-effectiveness of health care. Currently, the Division's 550+ staff are working on more than 350 ongoing research studies in behavioral health and aging, cancer, cardiovascular and metabolic conditions, health care delivery and policy, infectious diseases, vaccine safety and effectiveness, and women's and children's health. For more information, visit http://www.
About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve approximately 9.1 million members in eight states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to kp.org/share.